News | April 17, 2013

MDCT Better Determines Transcatheter Aortic Valve Implant Size

Study looks at patients who underwent an MDCT scan and transthoracic and transesophageal echocardiography before having a TAVI

April 17, 2013 — Multi-detector computed tomography (MDCT) is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation (TAVI) than two dimensional echocardiography according to a new study.

The study included 69 patients who underwent an MDCT scan as well as transthoracic and transesophageal echocardiography before having a TAVI. TAVI is done to treat patients with severe aortic stenosis who are not surgical candidates. Aortic stenosis is a common disorder in the elderly.

"Measurement of the aortic annulus is crucial for implant size selection and procedure success," said Vineeta Sethi, M.D., lead author of the study. "If the implanted valve is too small, blood will leak outside of the valve apparatus back into the heart."

Measurements obtained on MDCT were significantly different than those obtained on echocardiography.

"The decision to use a certain valve size would have been changed in about 55 percent of patients in our study if MDCT measurements had been used rather than echocardiography measurements," she said. "This includes patients who were wrongly sized as well as those who would have been disqualified from having TAVI due to the large size of their aortic annulus.”

She also stated that transesophagea/transthoracic echocardiographically derived measurements of the aortic annulus are the current standard for measurement but with the increasing awareness of the discrepancies in measurement between MDCT and echocardiography, more people are using MDCT derived measurements to choose appropriate valve size.

For more information: www.arrs.org

 


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now